| 查看: 134 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[交流]
求助：英文翻译（药学）
|
|||
|
In this , a drug is monobiotinylated in parallel with the production of a vector/avidin or a vector/strept avidin (SA) fusion protein. The biotinylated drug is produced in one vial and the vector/avid in fusion protein is produced in another vial, and the 2 vials are mixed before administration. Owing to the extremely high affinity of avid in or SA binding of biotin, there is instantaneous capture of thebiotinylatedneurotherapeutic agent by the vector/avid in or vector/SA fusion protein. Monoclonal antibody/avid in andmab/SA fusion genes and fusion proteins are produced with genetic engineering. Brain drug delivery in rats is possible with the OX26 mousemab to the rat tfr. Brain drug delivery in humans is possible with the genetically engineeredchimeric HIRmab. The activity of the genetically engineeredchimeric HIRmab is identical to that of the originalmurine HIRmab and thechimeric antibody is avidly taken up by the primate brain. The brain uptake of the HIRmab in the rhesus monkey is 2% to 4% of the injected dose which is a level of brain uptake that is 1 to 2 log orders greater than the brain uptake of aneuroactive small molecule such as morphine. |
回复此楼» 猜你喜欢
302求调剂一志愿华中师范大学
已经有8人回复
-
338求调剂
已经有6人回复
-
化学调剂
已经有12人回复
-
342求调剂
已经有5人回复
-
0835学硕299求调剂 08大类可接受
已经有4人回复
-
085602调剂 初试总分335
已经有3人回复
-
288环境专硕,求调材料方向
已经有5人回复
-
申博
已经有5人回复
-
081200-11408-276学硕求调剂
已经有5人回复
-
085600调剂
已经有4人回复
